Antibody responses in invasive group B streptococcal infection in adults

被引:11
作者
Wessels, MR
Kasper, DL
Johnson, KD
Harrison, LH
机构
[1] Brigham & Womens Hosp, Channing Lab, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med,Div Infect Dis, Boston, MA USA
[3] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA
[4] Univ Pittsburgh, Dept Med, Pittsburgh, PA USA
[5] Johns Hopkins Univ, Sch Hyg & Publ Hlth, Dept Int Hlth, Baltimore, MD USA
关键词
D O I
10.1086/517476
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Nonpregnant adults with group B streptococcus bacteremia were identified by active surveillance in three hospitals. Serum samples collected within 2 days of the time of blood culture were assayed for IgG antibodies to the capsular polysaccharide of the infecting strain: serotype Ia (3 isolates), III (5 isolates), or V (4 isolates). In 7 of 12 bacteremia episodes, the serum level of IgG to the infecting isolate was greater than or equal to 3.5 mu g/mL, higher than the 1-2 mu g/mL level thought to be protective in neonates, Among selected acute-phase sera, 4 of 5 that contained greater than or equal to 3.5 mu g/mL specific IgG mediated efficient opsonophagocytic killing of the corresponding group B streptococcus isolate in vitro. High levels of specific antibodies during the acute phase of invasive group B streptococcus infection in nonpregnant adults may reflect a rapid antibody response to infection or, in some cases, may indicate that susceptibility is due to defects in other immune effecters.
引用
收藏
页码:569 / 572
页数:4
相关论文
共 15 条
[1]  
BAKER CJ, 1985, REV INFECT DIS, V7, P458
[2]  
BALTIMORE RS, 1977, J IMMUNOL, V118, P673
[3]   Invasive group B streptococcal disease: The emergence of serotype V [J].
Blumberg, HM ;
Stephens, DS ;
Modansky, M ;
Erwin, M ;
Elliot, J ;
Facklam, RR ;
Schuchat, A ;
Baughman, W ;
Farley, MM .
JOURNAL OF INFECTIOUS DISEASES, 1996, 173 (02) :365-373
[4]   A POPULATION-BASED ASSESSMENT OF INVASIVE DISEASE DUE TO GROUP-B STREPTOCOCCUS IN NONPREGNANT ADULTS [J].
FARLEY, MM ;
HARVEY, RC ;
STULL, T ;
SMITH, JD ;
SCHUCHAT, A ;
WENGER, JD ;
STEPHENS, DS .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (25) :1807-1811
[5]   PREVALENCE OF ANTI-GROUP-B STREPTOCOCCAL TYPE-III CAPSULAR IGG ANTIBODIES IN THE UNITED-KINGDOM AND AN ANALYSIS OF THEIR SPECIFIC IGG SUBCLASSES [J].
FELDMAN, RG ;
FERRANTE, A .
JOURNAL OF INFECTIOUS DISEASES, 1990, 162 (04) :883-887
[6]   QUANTITATION OF IGG ANTIBODY TO THE TYPE-SPECIFIC POLYSACCHARIDE OF GROUP-B STREPTOCOCCUS TYPE-1B IN PREGNANT-WOMEN AND INFECTED INFANTS [J].
GOTOFF, SP ;
PAPIERNIAK, CK ;
KLEGERMAN, ME ;
BOYER, KM .
JOURNAL OF PEDIATRICS, 1984, 105 (04) :628-630
[7]   SEROEPIDEMIOLOGY OF GROUP-B STREPTOCOCCUS TYPE-III COLONIZATION AT DELIVERY [J].
GRAY, BM ;
PRITCHARD, DG ;
DILLON, HC .
JOURNAL OF INFECTIOUS DISEASES, 1989, 159 (06) :1139-1142
[8]   Quantitative determination of antibodies to type III group B streptococcal polysaccharide [J].
Guttormsen, HK ;
Baker, CJ ;
Edwards, MS ;
Paoletti, LC ;
Kasper, DL .
JOURNAL OF INFECTIOUS DISEASES, 1996, 173 (01) :142-150
[9]   Serotype distribution of invasive group B streptococcal isolates in Maryland: Implications for vaccine formulation [J].
Harrison, LH ;
Elliott, JA ;
Dwyer, DM ;
Libonati, JP ;
Ferrieri, P ;
Billmann, L ;
Schuchat, A .
JOURNAL OF INFECTIOUS DISEASES, 1998, 177 (04) :998-1002
[10]   RISK-FACTORS FOR GROUP-B STREPTOCOCCAL DISEASE IN ADULTS [J].
JACKSON, LA ;
HILSDON, R ;
FARLEY, MM ;
HARRISON, LH ;
REINGOLD, AL ;
PLIKAYTIS, BD ;
WENGER, JD ;
SCHUCHAT, A .
ANNALS OF INTERNAL MEDICINE, 1995, 123 (06) :415-420